EP Patent

EP4403171A3 — Microtubule polymerization inhibitor prodrugs and methods of using the same

Assigned to University of Maryland Baltimore · Expires 2024-09-11 · 2y expired

What this patent protects

Prodrugs of colchicine, de-acetyl colchicine, colcemid, and nocodazole are provided as therapies for the treatment of diseases ameliorated by the inhibition of microtubule polymerization.

USPTO Abstract

Prodrugs of colchicine, de-acetyl colchicine, colcemid, and nocodazole are provided as therapies for the treatment of diseases ameliorated by the inhibition of microtubule polymerization.

Drugs covered by this patent

Patent Metadata

Patent number
EP4403171A3
Jurisdiction
EP
Classification
—
Expires
2024-09-11
Drug substance claim
No
Drug product claim
No
Assignee
University of Maryland Baltimore
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.